Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory bowel disease.

Daryl Fish1, Subra Kugathasan

  • 1Division of Pediatric Gastroenterology and Nutrition, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.

Adolescent Medicine Clinics
|July 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic determinants of childhood onset systemic lupus erythematosus.

Lupus science & medicine·2026
Same author

Baseline stool TIMP-2 predicts strictures and penetrating disease progression in Crohn's patients.

Frontiers in immunology·2026
Same author

Automated Eosinophil Quantification Using Deep Learning to Predict Therapy Escalation in Pediatric Ulcerative Colitis.

Clinical and translational gastroenterology·2026
Same author

Unique challenges faced by tweens and teens with inflammatory bowel disease: a global perspective.

Inflammatory bowel diseases·2026
Same author

Timing is Everything: Lessons Learned for Building Microbiome-Based Models in Pediatric Crohn's Disease.

Inflammatory bowel diseases·2026
Same author

Probable Stricturing in Small Bowel Crohn Disease: In Support of SAR Consensus Recommendations.

AJR. American journal of roentgenology·2026
Same journal

Adolescent psychopharmacology: drugs for mood disorders.

Adolescent medicine clinics·2006
Same journal

Asperger's syndrome.

Adolescent medicine clinics·2006
Same journal

Prescription drug misuse: a growing national problem.

Adolescent medicine clinics·2006
Same journal

Abuse of proprietary (over-the-counter) drugs.

Adolescent medicine clinics·2006
Same journal

Performance-enhancing drug use in young athletes.

Adolescent medicine clinics·2006
Same journal

Tobacco use cessation for adolescents.

Adolescent medicine clinics·2006
See all related articles

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), affects children and adolescents. This review covers IBD causes, diagnosis, and treatments, addressing growth and psychological health.

Area of Science:

  • Gastroenterology
  • Pediatric Medicine
  • Immunology

Background:

  • Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), comprises chronic, relapsing inflammatory conditions of the gastrointestinal tract.
  • These idiopathic diseases typically emerge in late childhood and adolescence, potentially causing significant patient morbidity.

Purpose of the Study:

  • To provide a comprehensive review of the current understanding of IBD etiopathogenesis.
  • To discuss emerging epidemiologic data, clinical presentations, and diagnostic evaluations for pediatric IBD.
  • To review conventional and novel therapies, emphasizing age-specific considerations in pediatric IBD management.

Main Methods:

  • Literature review of current research on IBD.
  • Analysis of etiopathogenesis, including genetics, gut microflora, and immune mechanisms.

Related Experiment Videos

  • Synthesis of data on epidemiology, clinical features, diagnostics, and therapeutic strategies.

    • Main Results:

    • Recent advancements in IBD understanding involve genetics, gut ecology, immune responses, and targeted biologic therapies.
    • Pediatric IBD presents unique challenges, including distinct clinical features and the need for age-specific management.
    • Comprehensive therapeutic strategies encompass both established and emerging treatments.

    Conclusions:

    • Understanding the multifaceted etiopathogenesis of IBD is crucial for effective management.
    • Pediatric IBD requires tailored approaches addressing growth, sexual development, and psychosocial well-being.
    • Ongoing research into novel therapies promises improved outcomes for patients with IBD.